Clinical Trial Update: Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for inhaled treprostinil in patients with sarcoidosis-associated pulmonary hypertension shows the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sarcoidosis

Drugs mentioned

• Tyvaso (treprostinil)

Snippet

Sponsor: University of Florida | Conditions: Sarcoidosis, Precapillary Pulmonary Hypertension | Phase 2 | Status: COMPLETED